[Resynchronization Therapy for Chronic Heart Failure: Diagnostic and Therapeutic Approaches]
Ye T Sabitov1, A A Dusypov1, A S Abdrakhmanov1
1Semey State Medical University.
Kardiologiia
|December 19, 2019
Summary
Resynchronization therapy (RT) improves quality of life and reduces hospitalizations and mortality in patients with chronic heart failure (CHF). Optimizing RT is key for managing severe left ventricular systolic dysfunction and wide QRS complex.
Area of Science:
- Cardiology
- Heart Failure Management
Background:
- Chronic heart failure (CHF) presents a significant challenge in modern cardiology.
- Resynchronization therapy (RT) is an established treatment modality for specific CHF patient populations.
Purpose of the Study:
- To analyze literature data on the efficacy of RT in patients with CHF.
- To evaluate RT's impact on quality of life, hospitalizations, and mortality.
- To discuss methods for optimizing RT.
Main Methods:
- Literature review and analysis of existing data on resynchronization therapy.
- Focus on patients with severe left ventricular systolic dysfunction and expanded QRS complex.
Main Results:
- RT demonstrates effectiveness in enhancing the quality of life for CHF patients.
- RT is associated with a reduction in hospitalizations and mortality rates.
- Optimizing RT protocols is crucial for maximizing patient benefits.
Conclusions:
- Resynchronization therapy is a valuable intervention for selected CHF patients.
- Effective RT implementation can lead to improved clinical outcomes and reduced healthcare burden.
- Further research into RT optimization strategies is warranted.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
211
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
211
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
849
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
849
01:30Heart Failure V: Medical Management
176
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
176
01:30Heart Failure IV: Classification and Diagnostic Evaluation
259
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
259
01:30Cardiomyopathy II: Dilated Cardiomyopathy
400
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
400
01:29Cardiomyopathy V: Interprofessional Care
274
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
274